JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
TH |
|
N
|
Nimble Holdings Co Ltd
HKEX:186
|
HK |
|
F
|
Fintech SA
WSE:FTH
|
PL |
|
Fibra Uno Administracion SA de CV
OTC:FBASF
|
MX |
|
Jowell Global Ltd
NASDAQ:JWEL
|
CN |
|
G
|
GSW Immobilien AG
F:GIB
|
DE |
|
Interlife Holdings Co Ltd
TSE:1418
|
JP |
|
I
|
Intralot Integrated Lottery Systems and Services SA
ATHEX:INLOT
|
GR |
|
Yantai Ishikawa Sealing Technology Co Ltd
SZSE:301020
|
CN |
|
Hansae Co Ltd
KRX:105630
|
KR |
Balance Sheet
Balance Sheet Decomposition
JSP Industrial Pharmacy (Thailand) PCL
JSP Industrial Pharmacy (Thailand) PCL
Balance Sheet
JSP Industrial Pharmacy (Thailand) PCL
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
3
|
0
|
0
|
1
|
624
|
96
|
|
| Cash |
3
|
0
|
0
|
1
|
624
|
96
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
27
|
210
|
|
| Total Receivables |
49
|
68
|
69
|
52
|
64
|
99
|
|
| Accounts Receivables |
39
|
56
|
58
|
44
|
32
|
72
|
|
| Other Receivables |
11
|
12
|
11
|
7
|
32
|
26
|
|
| Inventory |
44
|
35
|
39
|
78
|
110
|
99
|
|
| Total Current Assets |
96
|
103
|
107
|
130
|
824
|
503
|
|
| PP&E Net |
110
|
151
|
147
|
215
|
397
|
669
|
|
| PP&E Gross |
110
|
151
|
147
|
215
|
397
|
669
|
|
| Accumulated Depreciation |
122
|
133
|
140
|
161
|
182
|
17
|
|
| Intangible Assets |
0
|
1
|
5
|
5
|
5
|
5
|
|
| Note Receivable |
4
|
0
|
6
|
0
|
0
|
0
|
|
| Long-Term Investments |
150
|
150
|
159
|
118
|
9
|
9
|
|
| Other Long-Term Assets |
24
|
30
|
18
|
17
|
26
|
36
|
|
| Total Assets |
385
N/A
|
436
+13%
|
442
+1%
|
484
+10%
|
1 261
+160%
|
1 222
-3%
|
|
| Liabilities | |||||||
| Accounts Payable |
42
|
29
|
30
|
30
|
40
|
46
|
|
| Accrued Liabilities |
23
|
28
|
16
|
16
|
0
|
0
|
|
| Short-Term Debt |
126
|
125
|
97
|
83
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
19
|
23
|
36
|
29
|
16
|
13
|
|
| Other Current Liabilities |
27
|
22
|
25
|
23
|
59
|
53
|
|
| Total Current Liabilities |
237
|
227
|
203
|
181
|
115
|
112
|
|
| Long-Term Debt |
74
|
90
|
65
|
97
|
168
|
147
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
4
|
8
|
9
|
10
|
12
|
21
|
|
| Total Liabilities |
315
N/A
|
325
+3%
|
277
-15%
|
288
+4%
|
294
+2%
|
280
-5%
|
|
| Equity | |||||||
| Common Stock |
100
|
130
|
160
|
170
|
228
|
228
|
|
| Retained Earnings |
30
|
19
|
5
|
4
|
6
|
19
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
22
|
734
|
734
|
|
| Total Equity |
70
N/A
|
111
+58%
|
165
+48%
|
196
+19%
|
966
+393%
|
942
-3%
|
|
| Total Liabilities & Equity |
385
N/A
|
436
+13%
|
442
+1%
|
484
+10%
|
1 261
+160%
|
1 222
-3%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
455
|
455
|
455
|
455
|
455
|
455
|
|